Dave, there are so many areas where Big Pharma can be legitimately criticised. I don’t think anyone here is a fan of Big Pharma. Opaque lobbying, revolving doors between regulatory agencies and big pharma, non-disclosure of trial data, price fixing, price gouging, ghost writing, funding patient action groups to advocate for expensive but not effective drugs to be made available on NHS and many other tactics.
It’s a money making business. Boards and top management are not directly accountable. Legislation and trade agreements almost mandate that making profit for investors is their over arching duty. Those are the things that need addressing. The duty of candour within the NHS is not that long a thing. Prior to that, lawyers advised against disclosure of information that might look bad for an NHS Trust in litigation and it was their duty to do so. These are tangiable things that can be addressed.